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Abstract: Mast cell tumors (MCTs) are one of the most common neoplasms in 
dogs. They originate from the bone marrow. Several criteria have been proposed 
for their classification, including histological grading and cell proliferation markers. 
The mitotic index, multiple nuclei, cells with bizarre nuclei and karyomegaly are the 
most important parameters for the classification of MCTs on high and low-grade 
malignancy. For the confirmation of MCT malignancy grade it is also important to 
determine the expression of the transmembrane kinase (KIT) receptor that has a 
significant role in the growth and differentiation of mast cell tumors. In high-grade 
malignancy MCTs in addition to membrane expression of the KIT receptor, aberrant 
cytoplasmic expression can be also observed. Fifty-two MCTs and 12 control 
samples of skin from dogs without MCTs were examined. Routinely processed tissue 
samples were stained with hematoxylin-eosin. Expression of KIT receptor was 
tested immunohistochemically. The classification of MCTs on high and low-grade 
malignancy was performed according to the Kiupel’s 2-tier classification and the 
expression of KIT receptors. Sixteen of 52 MCTs were of a low-grade malignancy, 
while thirty-six were classified as a high-grade malignancy of which 19 MCTs 
showed aberrant cytoplasm labelling of KIT receptor. All 16 low-grade malignancy 
MCTs had only membrane expression of KIT receptor. Most high-grade malignancy 
MCTs showed cytoplasmic KIT expression indicating the link between aberrant 
KIT expression and increased cell proliferation. The presence of mitotic figures, 
multinucleated cells, bizarre nuclei and karyomegaly, as well as KIT receptor 
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Mast cell tumors are the most 
common round cell tumors in dogs, and 
at the same time are the most common 
skin tumors in this animal species (Welle 
et al., 2008). Mast cell tumors belong 
to a group of mesenchymal tumors 
of the skin and soft tissues (Hendrick 
et al., 1998). They are composed of 
differentiated mast cells, which are seen 
as round cells with different amounts of 
granules in the cytoplasm, sorted into 
rows or groups (Strefezzi et al., 2009; 
Jovanović et al., 2012). Mast cell tumors 
in dogs are most commonly found on 
the trunk (50-60%), extremities (25-
40%), head and neck (10%). This tumor 
is less common on scrotum, perineum, 
back and tail (Welle et al., 2008). 
The macroscopic appearance of mast 
cell tumors varies from the degree of 
differentiation. Well-differentiated mast 
cell tumors are most commonly present 
as nodular, nonencapsulated rubber-
like mass, above which the areas of the 
skin are hairless. The size varies from 1 
to 4 cm in diameter and they clinically 
resembles lipoma. Poorly differentiated 
mast cell tumors have a tendency for 
faster growth, they are less limited and 
often accompanied by inflammation and 
edema of the surrounding tissue (Jubb et 
al., 2007). Ulceration may occur on their 
surface, while smaller nodes (satellite 
nodules) may develop nearby. Most 
mast cell tumors are not pigmented, 
but erythematous and hyperpigmented 
nodules (Welle et al., 2008) can be 
observed in occasional findings. The 
lesions at the distal parts of the limbs, 
the lips and the groin area may be in 
the form of poorly defined swellings or 
resembling acral lick dermatitis (eng.) 
(Gross et al., 2005; Welle et al., 2008). 
Malignant mast cell tumors can spread 
throug lymph or blood, and in most 
cases, the first sign of metastasis is the 
enlargement of the regional lymph node. 
Spread to the lungs is not common, 
while they will most likely spread to the 
spleen, liver and kidneys. Also they can 
often be diagnosed on the skin (Morris 
et al., 2001).
Etiology of mast cell tumors is not 
fully known, but it is considered, as 
with most tumors, to be multifactorial. 
The predisposition of certain breeds 
shows the importance of genetic in the 
appearance of MCTs (Welle et al., 2008). 
Recent papers also emphasize the role 
of surface receptor tyrosine kinase (KIT 
protein, CD117) (Vucicevic et al., 2016; 
Halsey et al., 2017). The diagnosis of 
mast cell tumors is based on the staining 
of cytologic smears obtained by fine 
needle biopsy or by using the impression 
smears technique. The most commonly 
used staining methods are Romanowsky 
expression pattern are the most important prognostic factors in dogs with mast cell 
tumor.
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staining (eg Diff-Quik, Giemsa, Wright’s) 
or New methylene blue (London et 
al., 2003; Strefezzi et al., 2009). While 
mast cell tumors can be determined 
on the basis of cytological staining, 
a histopathological examination of 
biopsy tissue is indispensable for tumor 
classification (Bostock, 1973; Patnaik et 
al., 1984; Kiupel et al., 2011). Mast cell 
tumors (especially poorly differentiated 
ones) can be mistaken for other round-
cell tumors (lymphoma, plasmacytoma, 
histiocytoma and transmissible venereal 
tumour) (Welle et al., 2008; Oliveira 
et al., 2012). For the purpose of 
confirming mast cell tumor diagnosis 
and differentiation from other tumors, 
toluidine blue (TB) is used for visualizing 
cytoplasmic granules (London et al., 
2003; Strefezzi et al., 2009).
The classification of mast cell tumors 
is very important when it comes to 
disease prognosis and type of therapy. 
The histologicalal examination of mast 
cell tumors is the primary classification 
determinant. More recently, a two-
stage classification system for mast cell 
tumors of high and low malignancy has 
been used. Based on this division, high 
malignancy mast cell tumors must meet 
at least one of the following criteria: 
at least 7 mitotic figures per 10 hpf 
(High-power Fields – hpf), at least 3 
multinucleated cells in 10 hpf, at least 3 
bizarre nuclei in 10 hpf or karyomegaly 
of at least 10% of neoplastic cells 
(Kiupel et al., 2011). The proposed 2-tier 
grading system should be used in any 
routine histological examination and 
diagnosis of mast cell tumors. For high 
grade malignancy MCTs, additional 
studies such as determination of KIT 
receptor expression and c-KIT mutation 
screening should be performed in order 
to determine adequate therapy (Kiupel 
et al., 2011, Sabattini et al., 2014).
KIT protein is growth factor receptor 
of stem cell and is normally found on the 
surface of hematopoietic cells and mast 
cells, playing a significant role in the 
growth and differentiation of these cells. 
This protein is a type III transmembrane 
receptor encoded by the proto- 
oncogene c-kit. KIT receptor expression 
was detected by immunohistochemical 
staining both on the surface of normal 
and on the surface of neoplastic 
mast cells. Increased expression was 
observed in poorly differentiated and 
undifferentiated MCTs (Welle et al., 
2008; El-Agamy, 2012). Apart from 
membrane expression, KIT expression 
was detected focally and diffusely in the 
cytoplasm.
The KIT-staining patterns are 
identified as pattern I - membrane-
associated staining due to the 
localization of KIT proteins in the cell 
membrane while cytoplasmic staining is 
present in small amounts or completely 
absent, pattern II - diffuse cytoplasmic 
staining and pattern III - also relates 
to the presence of KIT proteins in 
the cytoplasm of the noplastic mast 
cells and is characterized by intense 
focal cytoplasmic staining. Expression 
disorders can contribute to neoplastic 
transformation (Misdorp, 2004; Takeuchi 
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The examinations included skin 
samples of 52 dogs in which MCT is 
suspected by clinical examination. 
Samples of unchanged skin of 12 adult 
dogs, sampled at autopsy, were used as 
control. Dogs of different breed and sex, 
ages 3 to 11, were from the territory of 
the Republic of Serbia. Histopathologic 
diagnosis was made at the Department 
of Pathology, Faculty of Veterinary 
Medicine, University of Belgrade.
Histopathology
Immediately after the skin tumor 
biopsy, the samples were fixed in 10% 
neutral buffered formalin for no more 
than 48 hours, after which they were 
processed in the LEICA TP1020 tissue 
processor. Paraffin blocks were cut 
using the LEICA RM 2235 microtome 
into 3-5 µm thick sections. The 
obtained preparations were stained 
with hematoxylin-eosin (HE) method. 
Preliminary pathohistologic diagnosis 
of MCTs was made on sections stained 
by hematoxylin-eosin, and for its 
confirmation, the slides were further 
stained by toluidin-blue staining kit. 
Histopathological features of the 
tumor, such as the presence of mitosis, 
multinucleated cells, cells with bizarre 
nuclei and karyomegaly, were analyzed 
on slaides stained with hematoxylin-
eosin. The number of these parameters 
was determined on ten high power 
fields of each tumor (400x), using the 
method described by Romansik et al. 
(2007). Based on these parameters, the 
tumors are classified into two levels of 
differentiation – high grade and low 
grade tumors.
Immunohistochemical staining
Formalin-fixed paraffin embedded 
tissue samples were cut into 5 µm 
thin sections, which were then 
stained using a multi-step indirect 
immunohistochemical (IHC) technique. 
The sections were incubated with a 
primary antibody CD117 (Rabbit anti-
Human Polyclonal Antibody (DAKO, 
A4502)) diluted with phosphate 
buffer saline (PBS) in a ratio of 1: 
400. Immunoreaction was visualized 
using DAB + (3,3’-diaminobenzidine 
tetra-hydrochloride, DAKO, K3468). 
Mayer’s hematoxylin was used for 
counterstaining. Appropriate positive 
and negative controls were used.
Morphometric analysis
For morphometric analysis, Olympus 
Cell B morphometric software and 
et al., 2010). The increased cytoplasmic 
expression of KIT receptors (focal 
or diffuse) is correlated with shorter 
survival of dogs with mast cell tumors 
and shorter intervals for remission of the 
disease compared to mast cell tumors 
with increased membrane expression 
(Webster et al., 2004). The aim of our 
study is to determine the link between 
the localization of KIT receptors and 
histologic grade of MCTs observed in 
dogs.
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Olympus ColorView III camera were 
used. The localization of KIT proteins 
was determined in the manner described 
in Webster et al. research (2007), since 
membrane KIT proteins and two types 
of cytoplasmic KIT proteins (focally and 
diffusely distributed in the cytoplasm) 
differ. -. Dominant KIT protein pattern 
was determined based on the presence 
in at least 10% of neoplastic tumor cells. 
Cells at the edges of the tumor were not 
taken into consideration.
Statistical analysis
Descriptive parameters, such as 
arithmetic mean and standard deviation, 
were used in the statistical analysis of 
the obtained results. Chi-square test was 
used to test and determine statistically 
significant differences. These tests 
determined the existence of a statistically 
significant difference between the tested 
parameters at the significance level of 
5% and 1%.
RESULTS
Histological analysis of tissue sections 
stained with hematoxylin and eosin 
revealed more than six mitotic figures 
per 10 hpf in 53.85% of MCTs (Figure 1a), 
while 46.15% of MCTs were characterized 
by poor mitotic activity. The presence of 
more than two multinucleated cells in 
10 hpf was observed in 59.61% of MCTs 
(Figure 1b). In 17.31% of MCTs, two 
multinucleated cells were present, while 
one multinucleated cell was observed in 
19.23% of MCTs on the same number of 
visual fields. Multinucleated cells were 
not observed in 3.85% of MCTs. More 
than two cells with bizarre nuclei in 10 
hpf were present in 55.77% of MCTs 
(Figure 1c). Two cells with bizarre nuclei 
on the same number of visual fields were 
observed in 7.69% MCTs, while one 
cell with bizarre nuclei was present in 
26.92% of MCTs. In 9.61% of MCTs, cells 
with bizarre nuclei were not detected. 
More than 10% of anaplastic mast cells 
with nuclei of about 8-10 micrometers 
in diameter were observed in 19.23% of 
MCTs, while 42.30% of MCTs contained 
less than 10% of the cells with increased 
nucleus (Figure 1d). In 38.46% of MCTs 
no karyomegaly was present.
Based on the criteria of Kiupel’s 
classification and established parameters 
(mitotic figures, multinucleated cells, 
bizarre nuclei and karyomegaly,) 
in diagnosed MCTs, 36 (69.23%) 
of MCTs corresponded to MCTs of 
higher malignancy, while 16 (30.77 
%) of MCTs were of a lower degree of 
malignancy. Immunohistochemical 
staining confirmed the presence of 
KIT receptors in skin tissue sections 
of the dogs with MCTs. Microscopic 
examination of the sections revealed 
three types of immunohistochemical 
staining patterns for KIT positive cells. 
The majority of MCTs in this study had 
KIT expression pattern I or membrane 
expression (63.46%) (Figure 1e). This 
group included all low grade malignancy 
MCTs and 17 out of 36 high grade 
malignancy MCTs. Expression pattern II 
was present in 21.15% mast cell tumors 
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(Figure 1f), all of which were high grade. 
None of the examined mast cell tumors 
had only pattern III, but combined 
patterns were observed, namely: 11.54% 
of MCTs exhibited membrane and focal 
cytoplasmic expression, while 3.85% 
of MCTs had membrane and diffuse 
cytoplasmic expression of KIT receptors. 
Figure 1. Skin, dog: a) The presence of mitotic figure in high grade MCT, HE; b) 
The presence of multinucleated cells in high grade MCTs, HE; c) The presence of 
cells with bizarre nuclei in high grade MCTs, HE; d) The presence of karyomegaly 
in high grade MCTs, HE; e) Expression of pattern I (membrane expression), CD117, 
LSAB2; f) Expression of pattern II (diffuse cytoplasmic expression), CD117, LSAB2;
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Mast cell tumors are the most 
common dog skin tumors, especially 
when it comes to certain breeds such 
as boxer, golden retriever, labrador 
retriever and others (Welle et al., 2008). 
Based on the results obtained in our 
study, the highest incidence of mast 
cell tumors was observed in golden 
retrievers (37.5%), followed by boxers 
(20.7%). Similar to these results, most 
authors state that mast cell tumors were 
most commonly diagnosed in boxers 
(London and Sarah, 2003; Webster et 
al., 2006a; Gil da Costa et al., 2007; 
Welle et al., 2008; Vucicic et al.., 2018). 
Others consider that although boxers 
have an increased risk of mast cell tumor 
formation, they are usually of low grade 
malignancy and have a more favorable 
prognosis (Thamm et al., 2007).
Histological examination appears 
to be the most consistent predictive 
parameter and is closely related to the 
2-tire classification system proposed by 
Kiupel (Kiupel et al., 2011) according 
to which mast cell tumors are divided 
into high grade and low grade MCTs. 
According to the 2-tire system, MCTs 
examined in our research have been 
classified in high grade and low grade 
MCTs. Out of 52 MCTs in dogs, thirty-six 
were high grade tumors, while sixteen 
MCTs had morphological characteristics 
indicating a low degree of malignancy. 
More than six mitotic figures per 10 hpf 
were detected in 77.78% of high grade 
MCTs, and the presence of mitotic figures 
is statistically significant parameter 
for classification of MCTs in this study. 
While some authors consider that low 
grade MCTs can metastasize, and that 
determining only the mitotic index is 
not a reliable way of predicting tumor 
behavior (Séguin et al., 2006; Webster et 
al., 2007); other authors consider mitotic 
activity to be an important feature 
for the prognosis of mast cell tumor 
behavior (Romansik et al., 2007; Kiupel 
et al., 2011). Some authors believe that 
mortality increases in cases where the 
mitotic index is greater than 5/10 hpf 
(O’Connell and Thomson, 2011).
The presence of more than two 
multinucleated cells in 10 hpf was 
observed in 86.11% of high-grade MCTs, 
indicating that this is a statistically 
significant indicator of MCTs 
classification. Some studies indicate 
that there is a significant correlation 
between the number of multinucleated 
cells in MCTs and survival time, so that 
survival time decreases with the increase 
in the number of multinucleated cells 
(Thompson, 2012).
In our study, the presence of more 
than two cells with bizarre nuclei in 
10 hpf was observed in 86.11% of high 
grade MCTs, while the presence of 
multinucleated cells in low grade MCTs 
was not observed.
 It was also observed that 27.78% 
of high grade MCTs contain more than 
10% anaplastic MCTs with nuclei of 8-10 
microns in diameter, indicating that 
the karyomegaly can not be considered 
DISCUSSION
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as a significant predictive factor in this 
study. There is a significant correlation 
between high grade MCTs and faster 
metastases, as well as a shorter survival 
time of patients (Kiupel et al., 2011; 
Stern, 2012). Therefore, for high grade 
mast cell tumors, additional tests such 
as determining the expression of KIT 
receptors and screening for mutations 
of c-KIT should be used in order to 
determine adequate therapy.
Recent studies indicate the existence 
of both normal (membrane) and 
aberrant cytoplasmic (focal and diffuse) 
KIT receptor expression of MCTs in 
dogs (Morini et al., 2004; Gil da Costa 
et al., 2007). Unlike previous studies 
(Reguera et al., 2000) which examined 
the relationship between intensity 
of immunohistochemical staining 
indicating the degree of KIT expression 
and the degree of tumor malignancy, 
our study examines the interconnection 
of aberrant expression of this protein 
and histopathological grade of mast cell 
tumor. In our study, it is observed that in 
low grade MCTs there is only membrane 
expression, while in high grade MCTs, in 
addition to membrane expression, there 
is also aberrant expression. From our 
results, it is noted that low grade MCTs 
have no aberrant expression of the KIT 
receptor. None of aberrant expression 
pattern is statistically significant in 
relation to other aberrant expression 
patterns.
However, the correlation between 
aberrant CD117 expression and the 
degree of tumor malignancy is clear. 
Some authors state that KIT receptor is 
a transmembrane protein, and as such, 
the immunoreactivity of this protein is 
localized on the cytoplasmic membrane 
of unchanged mast cells. The results of 
the study confirm that canine MCTs that 
have more aggressive biological behavior, 
they also have greater cytoplasmic KIT 
expression (Kiupel et al., 2004). Also, the 
same authors claim that mast cells with 
increased cytoplasmic KIT expression 
have an increased risk of local recurrence 
and shorter survival time. Some 
authors emphasize a strong correlation 
between the cytoplasmic (aberrant) 
immunoexpression and increased cell 
proliferation, and therefore a higher 
degree of malignancy, but they did not 
notice significant differences between 
the focal and diffuse cytoplasmic CD117 
expression, suggesting that focal and 
diffuse cytoplasmic expression of 
KIT receptor may reflect similar cell 
changes. It is known that cytoplasmic 
KIT receptor expression is associated 
with both necrotic and ulcerative 
changes. Cytoplasmic KIT receptor 
expression is related to increased mast 
cell proliferation, and the occurrence 
of necrosis in mast cell tumors can be a 
reflection of increased cell proliferation 
which appropriate angiogenesis isn’t 
able to follow. On the other hand, the 
correlation between the cytoplasmic 
KIT receptor expression and occurrence 
of epidermal ulcerations can be due to 
KIT-mediated release of histamine and 
serotonin, which causes intense itching 
(Gil da Costa et al., 2007).
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More recently, the presence of c-kit 
proto-oncogene mutation and aberrant 
KIT expression are considered to be 
the most prominent predictive factors. 
However, some papers state that 
aberrant KIT receptor expression can 
be seen in high grade MCTs in which no 
mutation was detected (Webster et al., 
2006, Vucicevic et al., 2016). Therefore, 
determination of KIT receptor expression 
should be part of routine diagnostics and 
classification of mast cell tumors in dogs.
CONCLUSION
LITERATURE
1. Bostock D.E., Crocker J., Harris K., Smith P (1989): Nucleolar organiser regions 
as indicators of post-surgical prognosis in canine spontaneous mast cell tumours. 
British Journal of Cancer 59(6): 915–18. 
2. El-Agamy D.S (2012): Targeting c-KIT in the therapy of mast cell disorders: 
current update. European Journal of Pharmacology 690(1-3): 1-3.
3. Gil da Costa R.M., Matos E., Rema A., Lopes C., Pires M.A., Gartner F (2007): 
CD117 immunoexpression in canine mast cell tumours: correlations with 
pathological variables and proliferation markers. BMC Veterinary Research 
21(3): 19.
4. Gross T.L., Ihrke P., Walder E.J., Affolter V.K (2005): Mast cell tumors. Skin 
Diseases of the Dog and Cat Clinical and Histopathologic Diagnosis. 2nd edn. 
Oxford, UK: Blackwell Science Ltd 853–65.
5. Halsey C.H.C., Thamm D.H., Weishaar K.M., Burton J.H., Charles J.B., Gustafson 
D.L., Avery A.C., Ehrhart E.J (2017): Expression of Phosphorylated KIT in Canine 
Mast Cell Tumor. Veterinary Pathology 54(3): 387-394.
6. Hendrick M.J., Mahaffey E.A., Moore F.M., Vos J.H., Walder E.J (1998): Mast cell 
tumors. In: World Health Organization International Histological Classification 
of Tumors of Domestic Animals, Histological Classification of Mesenchymal 
Tumors of the Skin and Soft Tissues of Domestic Animals. 2nd series, ed. 
Schulman FY, 28–29. Armed Forces Institute of Pathology, Washington, DC.
7. Jovanović M., Aleksić-Kovačević S., Knežević M (2012): Specijalna veterinarska 
patologija, Makarije d.o.o., Beograd.
8. Jubb, Kennedy, Palmer (2007): Pathology of Domestic Animals, Saunders 
Elsevier, 5th edition, 771-73.
9. Kiupel M., Webster J.D., Kaneene J.B., Miller R., Yuzbasiyan-Gurkan V (2004): 
The use of kit and tryptase expression patterns as prognostic tools for canine 
Veterinary Journal of Republic of Srpska (Banja Luka), Vol.XVIII, No.2, 370 – 391, 2018 
Vučićević et all:
Important histological and immunochemical parameters for classification of mastocytoma in dogs
390
cutaneous mast cell tumors Vet Pathol 41(4): 371-77.
10. Kiupel M., Webster J.D., Bailey K.L., Best S., DeLay J., Detrisac C.J. i sar. (2011): 
Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell 
Tumors to More Accurately Predict Biological Behavior. Veterinary Pathology 
48(1): 147-55.
11. London C.A., Seguin B (2003): Mast cell tumors in the dog. Veterinary Clinics of 
North America Small Animal Practice 33(3): 473-89.
12. Misdorp W (2004): Mast cells and canine mast cell tumours: a review. Veterinary 
Quarterly 26(4): 156-69.
13. Morris J., Dobson J (2001): Small Animal Oncology. Blackwell Science 59-62.
14. O’Connell K., Thomson M (2011): Evaluation of prognostic indicators in dogs 
with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases. 
Veterinary and Comparative Oncology 11(1): 51-62.
15. Oliveira F.N., Elliott J.W., Lewis B.C., Mathews G.G., Brown R.M., Treadway 
C.M., Langohr I.M (2013): Cutaneous Mast Cell Tumor With Epitheliotropism in 
3 Dogs. Veterinary Pathology 50(2): 234-37.
16. Patnaik A.K., Ehler W.J., MacEwen E.G (1984): Canine cutaneous mast cell 
tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 
21(5): 469-74.
17. Reguera M.J., Rabanal R.M., Puigdemont A., Ferrer L (2000): Canine mast cell 
tumors express stem cell factor receptor. Am J Dermatopathol 22(1): 49-54.
18. Romansik E.M., Reilly C.M., Kass P.H., Moore P.F., London C.A (2007): Mitotic 
index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol 
44(3): 335-41.
19. Sabattini S., Scarpa F., Berlato D., Bettini G (2014): Histologic grading of canine 
mast cell tumor: Is 2 better than 3?. Vet. Pathol 52(1): 70-3
20. Seguin B., Besancon M.F., McCallan J.L. I sar. (2006): Recurrence rate, clinical 
outcome, and cellular proliferation indices as prognostic indicators after 
incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs 
(1994-2002). J Vet Intern Med 20: 933-940.
21. Stern W.A (2012): Histologic Grading of Canine Cutaneous Mast Cell Tumors: Is 
There a Good System?. J Vet Sci Med Diagn 1: 1.
22. Strefezzi R.F., Kleeb S.R., Xavier J.G., Catao-Dias J.L (2009): Prognostic 
indicators for mast cell tumors. Bray J Vet Pathol 2: 110-21.
Veterinary Journal of Republic of Srpska (Banja Luka), Vol.XVIII, No.2, 370 – 391, 2018 
Vučićević et all:
Important histological and immunochemical parameters for classification of mastocytoma in dogs
391
23. Takeuchi Y., Fujino Y., Watanabe M., Nakagawa T., Ohno K., Sasaki N., Sugano 
S., Tsujimoto H (2010): Aberrant autophosphorylation of c-KIT receptor in 
canine mast cell tumor cell lines. Vet. Immunol. Immunopathol 137(3-4): 208-
16.
24. Thamm D.H., Vail D.M: Mast cell tumors, In: Withrow SJ, MacEwen EG, editors 
(2007): Small Animal Clinical Oncology, Saunders, Philadelphia.
25. Thompson J.J (2012): Canine Mast Cell Tumours: Characterization of 
Subcutaneous Tumours and Receptor Tyrosine Kinase Profiling. PhD Thesis, 
Guelph, Ontario, Canada.
26. Vučićević, I., Marinković, D., Kukolj, V., Nešić, S., Aničić, M., Aleksić-Kovačević, 
S (2016): Kit receptor expression in canine cutaneous mast cell tumours (CMCTS) 
without c-kit mutation. Acta Veterinaria-Beograd 66 (2): 222-233
27. Vučićević I., Marinković D., Kukolj V., Nesić S., Aničić M., Aleksić-Kovačević 
S (2018): Mast cell tumor within a lipoma in a white toy poodle. Veterinarski 
Glasnik, 72 (1): 64-67.
28. Webster J.D., Kiupel M., Kaneene J.B., Miller R., Yuzbasiyan-Gurkan V (2004): 
The use of KIT and tryptase expression patterns as prognostic tools for canine 
cutaneous mast cell tumors. Vet Pathol 41(4): 371-7. 
29. Webster J.D., Yuzbasiyan-Gurkan V., Kaneene J.B., Miller R., Resau J.H., Kiupel 
M., (2006): The role of c-KIT in tumorigenesis: evaluation in canine cutaneous 
mast cell tumors. Neoplasia 8(2): 104-11. 
30. Webster J.D., Yuzbasiyan-Gurkan V., Miller R.A., Kaneene J.B., Kiupel M (2007): 
Cellular proliferation in canine cutaneous mast cell tumors: associations with 
c-KIT and its role in prognostication. Veterinary Pathology 44(3): 298-308.
31. Welle M.M., Rohrer C.B., Howard J., Rüfenacht S (2008): Canine mast cell tu-
mours: a review of the pathogenesis, clinical features, pathology and treatment. 
Veterinary Dermatology 19(6): 321-39.
Paper received: 30.04.2018.
Paper accepted: 11.10.2018.
